ENBIOSIS Biotechnology

?? We are proud to share that our research paper, "Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome," has now received 29 citations! This high citation rate is one of the first in the Personalized Nutrition field, demonstrating that we are pioneering and leading the way in this transformative area. It reflects the growing recognition of AI-driven personalized nutrition in managing IBS and advancing precision health. A big thank you to all researchers and practitioners contributing to this field! At Enbiosis, we are committed to shaping the future of microbiome-based AI solutions for better health outcomes. Let’s continue breaking new ground together! ?? Read the full study: https://lnkd.in/dmbePFB6 #Enbiosis #AI #PersonalizedNutrition #Microbiome #IBS #PrecisionHealth #ScientificImpact

Our study, "Microbiome-based AI-assisted personalized diet vs. low FODMAP: A novel approach to IBS management," published in the American Journal of Gastroenterology, has been invited for presentation at the 2025 Annual Meeting of the German Society for Neurogastroenterology and Motility (DGNM). ?? March 2, 2025 | 9:00 AM | Clinical Session V Join us as we unveil how AI-driven, microbiome-based personalized nutrition is redefining IBS management—surpassing conventional dietary strategies and unlocking a new era of precision care. #DGNM2025 #PrecisionMedicine #Microbiome

?? Enbiosis Launches a Clinical Study on Dry Eye Disease! At Enbiosis, we are dedicated to pushing the boundaries of microbiome-based personalized nutrition beyond gastroenterology. After revolutionizing gut health, we are now expanding our research to validate the impact of our innovative approach in other health conditions. We are excited to announce the launch of our clinical study on Dry Eye Disease, aiming to explore how microbiome-based interventions can support eye health and improve quality of life. Stay tuned for updates as we continue to pioneer the future of personalized healthcare! #Microbiome #PersonalizedNutrition #DryEyeDisease #ClinicalResearch #Innovation #Enbiosis

?? Exciting News from Axel Health Group! ?? We’re thrilled to announce our strategic partnership with ENBIOSIS Biotechnology! ?? This collaboration introduces advanced AI-powered gut microbiome analysis to the Vietnamese community, revolutionizing healthcare with precision nutrition and personalized solutions. Together, we aim to deliver impactful innovations that enhance well-being across Vietnam. Thank you British Chamber of Commerce Vietnam for connecting us. Stay tune for more updates as we redefine the future of healthcare ! ??? #HealthcareInnovation #AIHealthcare #GutHealth #PrecisionMedicine #VietnamHealthcare #Enbiosis #AxelHealthGroup #RevolutionizingHealthcare

?? We’re excited to share that Vietnam is now the 20th country where Enbiosis is expanding its presence! ?? As we continue our mission to revolutionize healthcare through AI-powered gut microbiome analysis, we are delighted to explore new collaborations that bring precision nutrition and personalized healthcare solutions to more communities. This collaboration brings together cutting-edge AI-driven healthcare solutions and Axel Health Group’s deep knowledge of regional healthcare ecosystems, ensuring sustainable and impactful healthcare innovations. Together, we are set to transform how gut health is understood and utilized in personalized medicine. Stay tuned for exciting developments as we bring the future of precision healthcare to more communities worldwide! #Enbiosis #Partnership #HealthcareInnovation #Vietnam #Microbiome #GutHealth #AXELHealthGroup #PrecisionMedicine #AIinHealthcare

?? Breaking News: Our Research Accepted at ESCMID - European Society of Clinical Microbiology and Infectious Diseases! ?? We’re thrilled to announce that our latest study, "Deep Learning-Enhanced Wellness Scores: A Population-Level Study on Gut Microbiome Profiling and Health Prediction," has been accepted for presentation at ESCMID Global- Congress of the European Society of Clinical Microbiology and Infectious Diseases –?one of the most renowned conferences in the field of clinical microbiology and infectious diseases. Previously, we demonstrated the power of personalized nutrition in top-tier journals. Now, we’re taking it a step further by showcasing the depth and precision of our AI-driven microbiome analysis at a global scientific stage. Stay tuned for more insights as we continue pushing the frontiers of precision health! #Microbiome #AI #PrecisionMedicine #ESCMID2025 #HealthTech ESCMID - European Society of Clinical Microbiology and Infectious Diseases

?? We are honored to be referenced in the recent review, "An Evidence-Based Update on the Diagnosis and Management of Irritable Bowel Syndrome", published in Expert Review of Gastroenterology & Hepatology. This comprehensive article discusses the limitations of traditional dietary and lifestyle interventions in IBS management, highlighting the need for innovative and personalized approaches. As noted in the review, "There is emerging evidence that response to a low FODMAP diet might be determined by a patient’s microbiome, and that microbiome-based artificial intelligence-assisted personalized diets might be more effective than a standard low FODMAP diet." While traditional methods have provided a foundation, the review emphasizes the growing need for advanced approaches as these methods may no longer fully address the complexities of IBS management. Beyond the limitations of known methods, Enbiosis offers a pioneering approach to IBS management and gut health modulation through its AI-driven microbiome solutions. ?? Read the review featuring Enbiosis: ?? https://lnkd.in/dYbNp2vf ?? Explore our publication: ?? https://lnkd.in/dnUT5_kR #IBS #GutHealth #Innovation #Microbiome #AI #Enbiosis

We are honored to be recognized as one of the Top 100 Startups of 2025, featured in the prestigious Startups 100 Index! ?? Startups.co.uk This achievement highlights our dedication to innovation and our mission to shape the future of microbiome technology. Joining the ranks of visionary brands like Monzo Bank, Deliveroo, and HelloFresh inspires us to continue breaking new ground and delivering impactful solutions. This milestone is a testament to the dedication of our team, the trust of our partners, and the support of our community. Thank you for being part of this journey. Together, we are shaping the future of gut health. Here’s to many more achievements ahead. Let’s keep building, innovating, and making a difference—together. ?? #innovation #startups #microbiome #AI #growth #Enbiosis #Startups100 ?mer ?ZKAN Startups.co.uk